The largest database of trusted experimental protocols

4 protocols using clone 11b11

1

Induction and Transfer of MOG-Specific Th17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from d5 MOG/CFA-immunized mice were cultured (106 cells per ml) in complete IMDM (Gibco) containing MOG35–55 (10 μg ml−1; GL Biochem), anti-IFNγ (10 μg ml−1; Clone XMG1.2, BioXCell) and anti-IL-4 (10 μg ml−1; Clone 11B11, BioXCell) with the addition of either no cytokines, TGFβ1 (2 ng ml−1; eBioscience) and IL-6 (20 ng ml−1; eBioscience), or IL-23 (10 ng ml−1; eBioscience). Cells were analysed after 3 days of culture. For transfer experiments, donor mice were immunized subcutaneously with 100 μg MOG35–55/CFA in footpads and hind flanks. Popliteal and inguinal lymph nodes were harvested 10 days post immunization and MOG-reactive Th17 cells expanded ex vivo in complete IMDM (Gibco) containing MOG35–55 (10 μg ml−1; GL Biochem) and IL-23 (3 ng ml−1; eBioscience) at a cell density of 106 cells per ml for 3 days. Before transfer, numbers of MOG-reactive Th17 (TCRβ+CD4+IL-17A+) cells in culture were determined following restimulation with PMA/Ionomycin/GolgiStop in complete IMDM for 4–5 h using flow cytometry. MOG-reactive Th17 cells (3 × 105) were adoptively transferred i.v. into pre-immunized congenic recipient mice as described in text.
+ Open protocol
+ Expand
2

T-cell Polarization Cytokine Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After cell transfection and/or treatment, supernatants were replaced by mouse T-cell culture medium or AIM V medium (Gibco) for human cells containing polarization cytokines as follows: anti-mouse IFN-γ (50 μg/mL, clone XMG 1.2; BioXCell) and anti-mouse IL-4 (50 μg/mL, clone 11B11; BioXCell) for mouse TH0 cells; IL-12 (10 ng/mL, Miltenyi Biotec) and anti-mouse IL-4 for mouse TH1 cells; TGF-β (2 ng/mL, Miltenyi Biotec), IL-4 (20 ng/mL, Miltenyi Biotec), and anti-mouse IFN-γ for mouse TH9 cells; IL-6 (20 ng/mL, Miltenyi Biotec), TGF-β, anti-mouse IFN-γ, and anti-mouse IL-4 for mouse TH17, IL-12 (10 ng/mL, R&D System) and anti-human IL-4 (3.5 μg/mL, clone MP4-25D2; BioXCell) for human TH1 cells, TGF-β (5 ng/mL, Miltenyi Biotec), IL-4 (10 ng/mL, R&D System), and anti-human IFN-γ (3.5 μg/mL, clone NIB42; BioLegend) for human TH9 cells. Unless specified otherwise, cells were cultured for 3 days at 37°C under 5% CO2.
+ Open protocol
+ Expand
3

Inflammatory Cell Recruitment Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected intraperitoneally (IP) with 2mL of 3% thioglycollate broth (Sigma-Aldrich) or injected IP with recombinant IL-4 (5μg, Peprotech) and anti-IL-4 ab (12.5μg, Clone 11B11, BioXcell) in a total volume of 100μl PBS on days 0 and 2. Then 3 or 4 days later, peritoneal exudates cells were obtained from peritoneal lavage and analyzed. To create an inflammatory microenvironment, mice were injected IP with 10mg/kg LPS (Sigma-Aldrich).
+ Open protocol
+ Expand
4

Differentiation and Characterization of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were differentiated as described before56 (link),57 (link). In brief, T cells were isolated from spleen and lymph nodes of WT mice. CD4+ T cells were purified using the Naive CD4+ T Cell Isolation Kit (Miltenyi, no. 130104453). Naive cells were cultured at a concentration of 1.5–2.0 × 106 per ml. Cells were seeded in the culture plates pre-coated with anti-CD3 antibody (2 μg ml−1 for effector T cells, 0.5 µg ml−1 for regulatory T cells) and anti-CD28 antibody (2 μg ml−1) (clone PV-1; all from Bio X Cell). For the differentiation of TH17 cells, naive T cells were cultured with IL-6 (30 ng ml−1, R&D, no. R&D406-ML), TGF-β (3 ng ml−1, R&D, no. R&D 240-B) and anti-IFN-γ (10 µg ml−1, clone XMG1.2, BioXCell, no. BE0055), for TH1 with IL-12 (10 ng ml−1), and anti-IL-4 (10 µg ml−1, clone 11B11, BioXCell, no. BE0045), for TReg TGF-β (3 ng ml−1), anti-IL-4 (10 µg ml−1) and anti-IFN-γ (10 µg ml−1). For TH17 differentiation, cells were supplemented with 10 ng ml−1 IL-23 (R&D, no. 1887-ML) after 48 h. HB-EGF (50 ng ml−1, Novus Biologicals, no. 35069) was added after 72 h for the rest of the differentiation. After 4 d, production of cytokines was measured by intracellular cytokine staining and subsequent flow cytometry as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!